Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6099402 | Journal of Crohn's and Colitis | 2014 | 13 Pages |
Abstract
Medical and surgical treatment improved HRQoL during the first year of disease. The majority of IBD patients in both Eastern and Western Europe reported a positive perception of disease-specific but not generic HRQoL. Biological therapy improved HRQoL in CD patients, while UC patients in need of surgery or biological therapy experienced lower perceptions of HRQoL than the rest.
Keywords
Short Inflammatory Bowel Disease QuestionnaireSIBDQIBDSF-12GCsHRQOLQuality of lifeEpidemiologyECCOinflammatory bowel disease unclassifiedCrohn's diseaseInflammatory bowel diseaseDisease courseShort form 12odds ratioUlcerative colitisHealth-related quality of lifeInception cohortGlucocorticosteroidsIBDU
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
J. Burisch, P. Weimers, N. Pedersen, S. Cukovic-Cavka, B. Vucelic, I. Kaimakliotis, D. Duricova, M. Bortlik, O. Shonová, I. Vind, S. Avnstrøm, N. Thorsgaard, S. Krabbe, V. Andersen, J.F. Dahlerup, J. Kjeldsen, R. Salupere, J. Olsen, P. Munkholm,